Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy
Clinical trial NCT03315364 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03315364
- Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2024-02-19
- Enrollment
- 549
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.